Next Generation Opto-GPCRs for Neuromodulatory Control
用于神经调节控制的下一代 Opto-GPCR
基本信息
- 批准号:10515612
- 负责人:
- 金额:$ 122.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-15 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAddressAdoptionAnimalsArrestinsBRAIN initiativeBehaviorBehavioralBehavioral AssayBiological AssayBiosensorBrainBrain DiseasesCalciumCell Culture TechniquesColorCommunicationCommunitiesComplexCoupledCouplingCryoelectron MicroscopyDatabasesDevelopmentDissectionElectrophysiology (science)EngineeringFiberG-Protein-Coupled ReceptorsGTP-Binding ProteinsGoalsImageIn VitroIonsKineticsLaboratoriesLibrariesLightMammalian CellMembraneMutationNeuromodulatorNeuronsNeurosciencesNeurotransmittersOpsinOpticsOrganismPathway interactionsPharmacologyPhotometryPhotophobiaPhysiologyPropertyProtein AnalysisProtein EngineeringPublishingReceptor SignalingResolutionRhodopsinSchemeSeriesSignal PathwaySignal TransductionSignaling ProteinSiteSliceSpecificityStructural BiologistStructureSynapsesSystemTechniquesTechnologyTestingTimeTranslatingValidationVariantWorkawakebehavior measurementbiological systemsbrain tissuecandidate selectioncell typehigh throughput screeningimaging approachin vivoinnovationmutantneuralneural circuitneuronal circuitryneurophysiologyneuroregulationnew technologynext generationnoveloptogeneticsreceptorscaffoldsensorsimulationspatiotemporalstructural biologytooltranslational potentialtwo-photon
项目摘要
Project Summary/Abstract: The field of optogenetics — utilizing light to engage biological systems — is
widely used for the dissection of neural circuits, cellular signaling and manipulating neurophysiological systems
in awake, behaving animals. However, while many new opsins have been developed and are actively used,
challenges still remain, and the current technology lacks a full toolbox for sub-cellular, spatiotemporal control of
signaling — the predominant means for neuromodulator communication in the brain. Here we propose, an
innovative effort combining neuroscience with structural biology and high-throughput pharmacology for the
development of a series of cutting-edge novel Opto-GPCRs that will allow spatiotemporally precise and
pathway-selective control of neuromodulator signaling in vitro and in freely moving animals. In four aims across
five leading laboratories, we will develop and test these novel tools in vitro and in vivo. Specifically, we will
work to 1) Develop and fully optimize OptoGPCR-v3.0 (Gi coupled) receptors for enhanced spectral
multiplexing and altered sensitivity using structure-function analysis together with mutant-library HTS landing
pad system; 2) Develop and fully optimize OptoGPCR-v3.0-Gq receptors for selective coupling to Gq signaling
pathways using structure-guidance and the HTS landing pad system; 3) Utilize databases of less-explored
naturally-occurring opsin-GPCRs to test, screen and further develop new optical tools with unique profiles; and
4) Assess the spectral compatibility for simultaneous use of OptoGPCR-v3.0 constructs in vivo, together with
biosensors using photometry, 2p imaging and concurrent behavioral measures in vivo. Successful completion
of the proposal will provide the wide neuroscience community with the long awaited capabilities of
spatiotemporal manipulation of GPCR – neuromodulator signaling within neural circuits in vitro and in vivo, in
awake freely behaving animals, and could be used for a wide variety of applications. This new technology will
also further widen the field for unique optical approaches that allow discrete control and optodynamic
simulation of neuromodulator function in brain tissue. We therefore believe that by the fulfilment of these goals
we directly address the central purpose of this RFA-NS-21-027 call.
项目摘要/摘要:光遗传学是利用光来参与生物系统的研究领域
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andre Berndt其他文献
Andre Berndt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andre Berndt', 18)}}的其他基金
High-throughput engineering of ligand-selective fluorescent biosensors for detecting endogenous and exogenous opioids
用于检测内源性和外源性阿片类药物的配体选择性荧光生物传感器的高通量工程
- 批准号:
10635413 - 财政年份:2023
- 资助金额:
$ 122.91万 - 项目类别:
Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen species
活性氧基因编码传感器的结构引导和高通量工程
- 批准号:
10092345 - 财政年份:2021
- 资助金额:
$ 122.91万 - 项目类别:
Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen species
活性氧基因编码传感器的结构引导和高通量工程
- 批准号:
10337219 - 财政年份:2021
- 资助金额:
$ 122.91万 - 项目类别:
In vivo real-time monitoring of reactive oxygen species and opioid signaling in a model for opioid receptor activity.
阿片受体活性模型中活性氧和阿片信号传导的体内实时监测。
- 批准号:
10369709 - 财政年份:2021
- 资助金额:
$ 122.91万 - 项目类别:
Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen species
活性氧基因编码传感器的结构引导和高通量工程
- 批准号:
10551906 - 财政年份:2021
- 资助金额:
$ 122.91万 - 项目类别:
Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen species
活性氧基因编码传感器的结构引导和高通量工程
- 批准号:
10797426 - 财政年份:2021
- 资助金额:
$ 122.91万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 122.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 122.91万 - 项目类别:
Standard Grant